NO20030717L - Forbindelser for behandling av avhengighetsforstyrrelser - Google Patents

Forbindelser for behandling av avhengighetsforstyrrelser

Info

Publication number
NO20030717L
NO20030717L NO20030717A NO20030717A NO20030717L NO 20030717 L NO20030717 L NO 20030717L NO 20030717 A NO20030717 A NO 20030717A NO 20030717 A NO20030717 A NO 20030717A NO 20030717 L NO20030717 L NO 20030717L
Authority
NO
Norway
Prior art keywords
compounds
treatment
addiction disorders
addiction
disorders
Prior art date
Application number
NO20030717A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030717D0 (no
Inventor
Richard W Anderson
Sylvia S Mcbrinn
David W Robertson
Robert Clyde Marshall
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20030717D0 publication Critical patent/NO20030717D0/no
Publication of NO20030717L publication Critical patent/NO20030717L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20030717A 2000-08-16 2003-02-14 Forbindelser for behandling av avhengighetsforstyrrelser NO20030717L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22571400P 2000-08-16 2000-08-16
US26361001P 2001-01-23 2001-01-23
PCT/US2001/025603 WO2002013807A2 (en) 2000-08-16 2001-08-13 Compounds for the treatment of addictive disorders

Publications (2)

Publication Number Publication Date
NO20030717D0 NO20030717D0 (no) 2003-02-14
NO20030717L true NO20030717L (no) 2003-02-14

Family

ID=26919847

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030717A NO20030717L (no) 2000-08-16 2003-02-14 Forbindelser for behandling av avhengighetsforstyrrelser

Country Status (17)

Country Link
US (2) US6841557B2 (cs)
EP (1) EP1363634A2 (cs)
JP (1) JP2004506621A (cs)
KR (1) KR20030024877A (cs)
AR (1) AR030364A1 (cs)
AU (2) AU2001283393B2 (cs)
BR (1) BR0112939A (cs)
CA (1) CA2413762A1 (cs)
CZ (1) CZ200380A3 (cs)
EA (1) EA200300271A1 (cs)
IL (1) IL154378A0 (cs)
MX (1) MXPA03001472A (cs)
NO (1) NO20030717L (cs)
NZ (1) NZ524741A (cs)
PE (1) PE20020288A1 (cs)
PL (1) PL363365A1 (cs)
WO (1) WO2002013807A2 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
WO2004032854A2 (en) * 2002-10-04 2004-04-22 Pharmacia Corporation Pharmaceutical compositions for treatment of parkinson's disease
DK3473251T3 (da) * 2002-12-20 2024-01-22 Niconovum Ab Nikotin-cellulose-kombination
US20070134169A1 (en) * 2005-12-11 2007-06-14 Rabinoff Michael D Methods for smoking cessation or alcohol cessation or other addiction cessation
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
ES2579853T3 (es) * 2010-09-20 2016-08-17 A.Carlsson Research Ab Compuestos de fenilpiperidina para el tratamiento de demencia

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526892A (en) 1981-03-03 1985-07-02 Farmitalia Carlo Erba, S.P.A. Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
US4935429A (en) * 1985-10-25 1990-06-19 Dackis Charles A Method of treating psychostimulant addiction
US4800204A (en) * 1987-05-07 1989-01-24 Mueller Peter S Method of controlling tobacco use
US4999382A (en) * 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use
US5273975A (en) 1989-06-09 1993-12-28 The Upjohn Company Heterocyclic amines having central nervous system activity
ES2067744T3 (es) * 1989-06-09 1995-04-01 Upjohn Co Aminas heterociclicas con actividad sobre el sistema nervioso central.
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency
AU8212491A (en) * 1990-06-29 1992-01-23 Upjohn Company, The Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity
AU653837B2 (en) 1991-04-17 1994-10-13 Pharmacia & Upjohn Company Substituted phenylazacycloalkanes as CNS agents
RU2131427C1 (ru) * 1992-12-24 1999-06-10 Фармация Энд Апджон С.П.А. Производные эрголина, способ их получения, фармацевтическая композиция
BR9405972A (pt) * 1993-04-06 1995-12-12 Abbott Lab Composto composição farmaceutica e processo para tratar distúrbios neurológicos psicológicos cardiovasculares cognitivos ou de falta de atenção ou de comportamento que levam ao vicio ou uso de substancias ou uma combinação destas indicações
JP3773255B2 (ja) 1993-12-28 2006-05-10 ファルマシア・アンド・アップジョン・カンパニー Ｃｎｓおよび心血管系疾患治療用複素環化合物
GB9407637D0 (en) * 1994-04-18 1994-06-08 Erba Carlo Spa Serotoninergic abeo-ergoline derivatives
US5874477A (en) * 1994-08-12 1999-02-23 The University Of Hawaii Method of treatment for malaria utilizing serotonin receptor ligands
KR100291882B1 (ko) * 1995-08-11 2001-10-26 디. 제이. 우드, 스피겔 알렌 제이 (1에스,2에스)-1-(4-하이드록시페닐)-2-(4-하이드록시-4-페닐피페리딘-1-일)-1-프로판올메탄설포네이트트리하이드레이트
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
GB9603226D0 (en) * 1996-02-15 1996-04-17 Pharmacia Spa Heterocyclyl-ergoline derivatives
US6001848A (en) * 1996-03-25 1999-12-14 The Regents Of The University Of California Bromocriptine for the treatment of alcoholics diagnosed with the D2 dopamine receptor DRD2 A1 allele
HN1998000118A (es) * 1997-08-27 1999-02-09 Pfizer Prod Inc 2 - aminopiridinas que contienen sustituyentes de anillos condensados.
GB9723544D0 (en) * 1997-11-07 1998-01-07 Merck Sharp & Dohme Therapeutic agents
EP1075278A1 (en) * 1998-01-13 2001-02-14 AstraZeneca UK Limited PHARMACEUTICAL COMPOSITIONS COMPRISING A COMPOUND HAVING DOPAMINE (D 2?) RECEPTOR AGONIST ACTIVITY AND A COMPOUND (B) HAVING $g(b) 2?-ADRENORECEPTOR AGONIST ACTIVITY
US6448293B1 (en) * 2000-03-31 2002-09-10 Pfizer Inc. Diphenyl ether compounds useful in therapy
WO2001081343A2 (en) * 2000-04-21 2001-11-01 Pharmacia & Upjohn Company Compounds for treating fibromyalgia and chronic fatigue syndrome

Also Published As

Publication number Publication date
US6841557B2 (en) 2005-01-11
CZ200380A3 (cs) 2004-01-14
MXPA03001472A (es) 2003-06-06
PL363365A1 (en) 2004-11-15
IL154378A0 (en) 2003-09-17
US20020049206A1 (en) 2002-04-25
KR20030024877A (ko) 2003-03-26
WO2002013807A2 (en) 2002-02-21
AR030364A1 (es) 2003-08-20
PE20020288A1 (es) 2002-03-31
US20030078273A1 (en) 2003-04-24
EP1363634A2 (en) 2003-11-26
NZ524741A (en) 2005-01-28
CA2413762A1 (en) 2002-02-21
NO20030717D0 (no) 2003-02-14
WO2002013807A3 (en) 2003-09-25
BR0112939A (pt) 2005-11-01
JP2004506621A (ja) 2004-03-04
AU2001283393B2 (en) 2005-09-22
AU8339301A (en) 2002-02-25
EA200300271A1 (ru) 2004-02-26

Similar Documents

Publication Publication Date Title
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
NO20031443L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20043237L (no) Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
IL150742A0 (en) Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
NO20033804L (no) Karbamatforbindelser for behandling av smerte
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20023803L (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20030717D0 (no) Forbindelser for behandling av avhengighetsforstyrrelser
NO20032156D0 (no) Behandling av angstforstyrrelser
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
IS6098A (is) Ósantant til meðhöndlunar á skaptruflunum
DK1468686T3 (da) S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser
NO20024887L (no) FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application